Not applicableStudy completedNCT00267826What this trial is testingImmunopharmacological Effects of Rituximab in Atopic DermatitisWho this might be right forDermatitis, Atopic University of Bern 6
Large-scale testing (Phase 3)Not Yet RecruitingNCT07189325What this trial is testingA Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple SclerosisWho this might be right forRelapsing-Remitting Multiple Sclerosis (RRMS)Anti-CD20 Therapy University Hospital, Montpellier 250
Early research (Phase 1)Study completedNCT01842386What this trial is testingRituximab for Anti-cytokine Autoantibody-Associated DiseasesWho this might be right forPulmonary Alveolar Proteinosis (PAP)Severe Mucocutaneous Candidiasis National Institute of Allergy and Infectious Diseases (NIAID) 7
Testing effectiveness (Phase 2)WithdrawnNCT00003605What this trial is testingRituximab Plus Cyclophosphamide in Treating Patients With Indolent Stage III or Stage IV Non-Hodgkin's LymphomaWho this might be right forLymphoma Hoag Memorial Hospital Presbyterian
Testing effectiveness (Phase 2)UnknownNCT04430530What this trial is testing4SCAR-T Therapy Post CD19-targeted ImmunotherapyWho this might be right forCD19 Negative B-cell Malignancies Shenzhen Geno-Immune Medical Institute 100
Testing effectiveness (Phase 2)Study completedNCT00229619What this trial is testingRituximab to Treat Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan AnemiaWho this might be right forAnemia, AplasticRed-Cell Aplasia, PureAnemia, Diamond-Blackfan National Heart, Lung, and Blood Institute (NHLBI) 11
Post-approval studies (Phase 4)UnknownNCT05828147What this trial is testingAnti-CD20 Antibodies for Treatment of SLE-PAHWho this might be right forSystemic Lupus ErythematosusPulmonary Arterial Hypertension Chinese SLE Treatment And Research Group 50
Testing effectiveness (Phase 2)Looking for participantsNCT05995054What this trial is testingA Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Immune ThrombocytopeniaWho this might be right forImmune ThrombocytopeniaTreatment Institute of Hematology & Blood Diseases Hospital, China 110
Testing effectiveness (Phase 2)Looking for participantsNCT04989803What this trial is testingStudy of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell LymphomaWho this might be right forRelapsed and/or Refractory B-cell Lymphoma Kite, A Gilead Company 247
Early research (Phase 1)Ended earlyNCT04160195What this trial is testingT Cells Expressing Fully-human Anti-CD19 and Anti-CD20 Chimeric Antigen Receptors for Treating B-cell Malignancies and Hodgkin LymphomaWho this might be right forLymphoma, B-CellLymphoma, Non-hodgkinsChronic Lymphocytic Leukemia+1 more National Cancer Institute (NCI) 2
Testing effectiveness (Phase 2)Looking for participantsNCT04523428What this trial is testingREtreatment With VEnetoclax and Acalabrutinib After Venetoclax Limited Duration (REVEAL)Who this might be right forCLL/SLL Stichting Hemato-Oncologie voor Volwassenen Nederland 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07206264What this trial is testingChemotherapy Combined With Targeted Therapy as First-line Treatment for Mantle Cell Lymphoma Based on MRD and PET-CT AssessmentWho this might be right forMantle Cell Lymphoma Tianjin Medical University Cancer Institute and Hospital 45
Large-scale testing (Phase 3)Study completedNCT04486716What this trial is testingA Single Arm Study Evaluating the Efficacy, Safety and Tolerability of Ofatumumab in Patients With Relapsing Multiple SclerosisWho this might be right forRelapsing Multiple Sclerosis Novartis Pharmaceuticals 111
Testing effectiveness (Phase 2)Looking for participantsNCT06688331What this trial is testingTreatment of Presymptomatic (Stage 1) Type 1 Diabetes Pediatric Patients With Treg Cell Preparations and Anti-CD20 AntibodyWho this might be right forPresymptomatic Diabetes Type 1 (Stage 1)Diabetes Mellitus, Type IDiabetes Mellitus, Type 1 PolTREG S.A. 150
Early research (Phase 1)Looking for participantsNCT07100873What this trial is testingADI-001 in Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis (RA) Adicet Therapeutics 25
Testing effectiveness (Phase 2)Study completedNCT00379431What this trial is testingA Protocol Based Treatment for Early and Severe Systemic Sclerosis With (Anti-CD20), RituximabWho this might be right forEarly and Severe Systemic Sclerosis University Hospital, Ghent 9
Post-approval studies (Phase 4)Active Not RecruitingNCT06049134What this trial is testingImmunogenicity and Clinical Efficacy of 20-valent Pneumococcal Conjugate Vaccine (PCV20) in Lymphoma Survivors After Treatment With Anti-CD20 TherapyWho this might be right forLymphoma M.D. Anderson Cancer Center 30
Not applicableLooking for participantsNCT07343089What this trial is testingReal-life Study of Disseminated Borreliosis Cases Occurring in Patients Receiving Anti-CD20 Treatment in FranceWho this might be right forBorrelia Infections University Hospital, Strasbourg, France 100
Not applicableEnded earlyNCT01083563What this trial is testingDraining PLN and Synovial Inflammation in RA Knee Joints Pre and Post Anti-TNF or B Cell Depletion TherapyWho this might be right forRheumatoid Arthritis University of Rochester 7
Testing effectiveness (Phase 2)Study completedNCT00003248What this trial is testingFludarabine and Monoclonal Antibody Therapy in Treating Patients With Untreated B-cell Chronic Lymphocytic LeukemiaWho this might be right forLeukemia Alliance for Clinical Trials in Oncology 104